- Home
- VRE vs SANA Comparison
VRE vs SANA Comparison
Compare VRE & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRE | SANA |
|---|---|---|
| Founded | 1949 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VRE | SANA |
|---|---|---|
| Price | $14.89 | $4.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $18.67 | $7.83 |
| AVG Volume (30 Days) | 725.4K | ★ 4.0M |
| Earning Date | 02-23-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $291,348,000.00 | N/A |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.23 | ★ N/A |
| Revenue Growth | ★ 6.39 | N/A |
| 52 Week Low | $13.69 | $1.26 |
| 52 Week High | $17.18 | $7.30 |
Technical Indicators
Market Signals| Indicator | VRE | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 51.35 | 52.36 |
| Support Level | $14.47 | $4.01 |
| Resistance Level | $15.39 | $4.91 |
| Average True Range (ATR) | 0.33 | 0.27 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 49.48 | 60.71 |
Price Performance
Historical ComparisonAbout VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.